Table 7. Registered clinical studies using nanoprticles in peritoneal carcinoma.
Conditions | Intervention | Enrollment | Phase | Number |
---|---|---|---|---|
Fallopian tube carcinoma Primaryperitonealcarcinoma Recurrent ovarian carcinoma | Nab-PTX | 51 | II | NCT00499252 |
Peritoneal carcinoma | Nanotax | 22 | I | NCT00666991 |
Ovarian cancer Peritoneal cavity cancer | Nab-PTX | 27 | I | NCT00825201 |